Egypt’s stock market closed the week of 8–12 February on a strong upward trajectory, buoyed by structural reform announcements and renewed foreign investor appetite. The benchmark EGX30 advanced 1.59% to 50,490.2 points, breaking decisively above the 50,000-point threshold and reinforcing bullish momentum that has been building since the start of the year. The rally coincided with a landmark announcement by the Egyptian Exchange outlining a new package of financial instruments designed to enhance liquidity and modernise market infrastructure.
At the heart of the reform package is the launch of a continuous trading system for government fixed income instruments, set to begin next week, alongside the introduction of derivatives trading on the EGX30 Index from 1 March, with expansion to the EGX70 Index to follow. Settlement will be processed through the Central Counterparty (CCP) framework and Tasweyaat Clearing Services, aimed at improving risk management and operational efficiency. The Exchange also confirmed collaboration with NASDAQ on a new trading system scheduled for July, enabling the trading of derivatives, carbon credits and bonds. Complementary developments include a short-selling mechanism developed by Misr for Central Clearing, alongside the integration of AI tools and XBRL reporting standards. With daily average trading already at EGP 6.9 billion, these enhancements signal a structural evolution of Egypt’s capital markets rather than a short-term stimulus.
Market performance reflected strong investor endorsement of these initiatives. The EGX33 Shariah Index rose 0.98% to 5,255.03 points, while the EGX35-LV gained 0.78% to 5,148.04 points. The SME-focused EGX70 advanced 0.59% to 12,931.2 points, indicating broader participation in the rally. The EGX100, however, slipped 0.62% to 17,929.64 points, suggesting selective profit-taking within parts of the mid-cap universe. Total market capitalization climbed to EGP 3.295 trillion, marking one of the highest recorded levels and underlining the scale of liquidity entering the market.
Investor flows were notably skewed toward foreign participation. Non-Arab foreign investors recorded net purchases of EGP 3.11 billion, while Arab investors added EGP 1.54 billion in net buying. Egyptians, by contrast, were net sellers with outflows of EGP 4.65 billion, reflecting portfolio rebalancing amid elevated price levels. The dominance of foreign inflows highlights growing international confidence in Egypt’s market reform trajectory and improving risk-adjusted return outlook.
At the stock level, healthcare and consumer-linked names led gains. Ismailia Misr Poultry climbed 9.98% to EGP 14.99, Minapharm Pharmaceuticals rose 9.52% to EGP 395.37, and Cleopatra Hospital Company gained 9.35% to EGP 12.63, benefiting from renewed defensive positioning and strong sector fundamentals. On the downside, Egyptian Iron & Steel declined 4.74% to EGP 36.18, while Gogreen for Agricultural Investment and Gourmet Egypt.Com Foods also posted moderate losses, reflecting sector-specific rotation rather than systemic weakness.
The broader message from the week is clear: the EGX is entering a new operational phase. The combination of structural market reforms, technological upgrades, and the introduction of derivatives and short-selling mechanisms is reshaping the investment landscape. With foreign capital driving the latest rally and liquidity conditions strengthening, the market appears to be transitioning from a purely equity-driven exchange into a more diversified financial platform. As February progresses, attention will turn to the implementation timeline of these instruments and whether trading volumes sustain current levels, but for now, reform momentum and foreign inflows are providing a powerful tailwind to Egypt’s capital market narrative.
